awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48109284-3FA972CB-3762-4BCD-87E2-DFC7528102DF
Q48109284-3FA972CB-3762-4BCD-87E2-DFC7528102DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48109284-3FA972CB-3762-4BCD-87E2-DFC7528102DF
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.
P2860
Q48109284-3FA972CB-3762-4BCD-87E2-DFC7528102DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48109284-3FA972CB-3762-4BCD-87E2-DFC7528102DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b7cb61de7553ee9966e59118dcc24aa74c3c217
P2860
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes.